IP Library Granted Patent US 7,786,073
Granted Patent B2
US 7,786,073 · App. 11/443,656 · Granted Aug 31, 2010

Container for dietary supplement having improved efficacy at time of consumption

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,786,073
App. No.
11/443,656
Granted
Aug 31, 2010
Kind
B2
Abstract

A dietary supplement that includes a container having a first compartment and a second compartment. The first compartment includes an aqueous medium. The second compartment includes an ingredient that is stable when stored within the second compartment. The container is configured such that a user may selectively cause the first and second compartments to be in communication with each other such that the ingredient of the second compartment is mixed with the aqueous medium of the first compartment. The ingredient, which may be creatine or a derivative thereof, is less stable after being mixed with the aqueous medium of the first compartment.

Claims (24)

1. A dietary supplement container comprising: a first compartment and a second compartment, the first compartment including a consumable aqueous medium, the second compartment including a mixture of ingredients comprising creatine or a salt thereof, calcium salt of ketoisocaproic acid and trometamol salt of alpha lipoic acid, wherein the salt of creatine comprises at least one of creatine monohydrate, creatine alpha ketoglutarate, creatine ethyl ester HCL, tricreatine hydroxycitrate, creatine citrate, creatine pyruvate, creatine pyroglutamate, dicreatine malate, creatine anhydrous, creatine taurinate, creatine lipoate, and creatine methyl ester; whereby said mixture is stable within the second compartment, the container being configured such that a user may selectively cause the first and second compartment to be in communication with each other such that the mixture within the second compartment is combined with the consumable aqueous medium within the first compartment, the mixture being less stable after being combined with the consumable aqueous medium of the first compartment.

2. The dietary supplement container of claim 1 , wherein the creatine or a salt thereof comprises at least one of creatine monohydrate, creatine alpha ketoglutarate, creatine ethyl ester HCl, tricreatine hydroxycitrate, creatine citrate, creatine pyruvate, creatine pyroglutamate, dicreatine malate, creatine anhydrous, creatine taurinate, creatine lipoate and creatine methyl ester.

3. The dietary supplement container of claim 1 , wherein the second compartment comprises a mixture of granular anhydrous creatine, calcium salt of ketoisocaproic acid, and trometamol salt of alpha lipoic acid.

4. The dietary supplement container of claim 3 , wherein the mixture comprises about 2.5 g of granular creatine, about 0.05 g of calcium salt of ketoisocaproic acid, and about 0.1 g of trometamol salt of alpha lipoic acid.

5. The dietary supplement container of claim 1 , wherein the second compartment comprises a mixture of creatine citrate, trometamol salt of alpha lipoic acid, creatine alpha ketoglutarate, creatine ethyl ester HCl, creatine methyl ester, dicreatine malate, granular anhydrous creatine, calcium salt of ketoisocaproic acid.

6. The dietary supplement container of claim 5 , wherein the mixture comprises about 5.0170 g of creatine citrate, about 0.0510 g of trometamol salt of alpha lipoic acid, about 0.0010 g of creatine alpha ketoglutarate, about 0.0010 g of creatine ethyl ester HCl, about 0.0010 g of creatine methyl ester, about 0.0010 g of dicreatine malate, about 0.00094 g of granular anhydrous creatine, about 0.00002 g of calcium salt of ketoisocaproic acid.

7. The dietary supplement container of claim 1 ,wherein the second compartment comprises a mixture of creatine citrate, trometamol salt of alpha lipoic acid, granular anhydrous creatine, calcium salt of ketoisocaproic acid, creatine alpha ketoglutarate, creatine pyroglutamate, dicreatine malate, L-glutamine, and taurine.

8. The dietary supplement container of claim 7 , wherein the mixture comprises about 4.994 g of creatine citrate, about 0.0510 g of trometamol salt of alpha lipoic acid, about 0.00094 g of granular anhydrous creatine, about 0.0002 g of calcium salt of ketoisocaproic acid, about 0.0010 g of creatine alpha ketoglutarate, about 0.0010 g of creatine pyroglutamate, about 0.0010 g of dicreatine malate, about 0.0010 g of L-glutamine and about 0.0010 g of taurine.

9. A dietary supplement container comprising: a first compartment of the container including a consumable aqueous medium; and a second compartment of the container including a mixture of ingredients comprising creatine or a salt thereof, calcium salt of ketoisocaproic acid and trometamol salt of alpha lipoic acid, wherein the salt of creatine comprises at least one of creatine monohydrate, creatine alpha ketoglutarate, creatine ethyl ester HCL, tricreatine hydroxycitrate, creatine citrate, creatine pyruvate, creatine pyroglutamate, dicreatine malate, creatine anhydrous, creatine taurinate, creatine lipoate, and creatine methyl ester; whereby said mixture is more stable when stored separately from the consumable aqueous medium as compared to when dissolved in the consumable aqueous medium, wherein, in a pre-use configuration of the container, the first and second compartments are not in communication with each other, and wherein, in use configuration of the container, the first and second compartments are in communication with each other and the mixture is combined with the consumable aqueous medium.

10. The dietary supplement container of claim 9 , wherein the creatine or a salt thereof comprises at least one of creatine monohydrate, creatine alpha ketoglutarate, creatine ethyl ester HCl, tricreatine hydroxycitrate, creatine citrate, creatine pyruvate, creatine pyroglutamate, dicreatine malate, creatine anhydrous, creatine taurinate, creatine lipoate and creatine methyl ester.

11. The dietary supplement container of claim 9 , wherein the second compartment comprises a mixture of granular anhydrous creatine, calcium salt of ketoisocaproic acid, and trometamol salt of alpha lipoic acid.

12. The dietary supplement container of claim 11 , wherein the mixture comprises about 2.5 g of granular anhydrous creative, about 0.05 g of calcium salt of ketoisocaproic acid, and about 0.1 g of trometamol salt of alpha lipoic acid.

13. The dietary supplement container of claim 9 , wherein the second compartment comprises a mixture of creatine citrate, trometamol salt of alpha lipoic acid, creatine alpha ketoglutarate, creatine ethyl ester HCl, creatine methyl ester, dicreatine malate, granular anhydrous creatine, calcium salt of ketoisocaproic acid.

14. The dietary supplement container of claim 13 , wherein the mixture comprises about 5.0170 g of creatine citrate, about 0.0510 g of trometamol salt of alpha lipoic acid, about 0.0010 g of creatine alpha ketoglutarate, about 0.0010 g of creatine ethyl ester HCl, about 0.0010 g of creatine methyl ester, about 0.0010 g of dicreatine malate, about 0.00094 g of granular anhydrous creatine, about 0.00002 g of calcium salt of ketoisocaproic acid.

15. The dietary supplement container of claim 9 , wherein the second comportment comprises a mixture of creatine citrate, trometamol salt of alpha lipoic acid, granular anhydrous creatine, calcium salt of ketoisocaproic acid, creatine alpha ketoglutarate, creatine pyroglutamate, dicreatine malate, L-glutamine, and taurine.

16. The dietary supplement container of claim 15 , wherein the mixture comprises about 4.994 g of creatine citrate, about 0.0510 g of trometamol salt of alpha lipoic acid, about 0.00094 g of granular anhydrous creatine, about 0.0001 g of calcium salt of ketoisocaproic acid, about 0.0010 g of creatine alpha ketoglutarate, about 0.0010 g of creatine pyroglutamate, about 0.0010 g of dicreatine malate, about 0.0010 g of L-glutamine and about 0.0010 g of taurine.

17. The dietary supplement container according to claim 1 , wherein the ingredient being more stable when stored separately from the consumable aqueous medium is separated from the consumable aqueous medium having a pH less than or equal to 7.

18. A dietary supplement container according to claim 1 , wherein the ingredient being more stable when stored separately from the consumable aqueous medium is separated from the consumable aqueous medium having a pH greater than or equal to 7.

19. A dietary supplement container according to claim 1 , wherein the ingredient being more stable when stored separately from the consumable aqueous medium is separated from the consumable aqueous medium being more acidic than the unstable ingredient.

20. The dietary supplement container according to claim 1 , wherein the unstable ingredient is separated from the consumable aqueous medium being more basic than the unstable ingredient.

21. A dietary supplement container according to claim 9 , wherein the ingredient being more stable when stored separately from the consumable aqueous medium is separated from the consumable aqueous medium having a pH less than or equal to 7.

22. A dietary supplement container according to claim 9 , wherein the ingredient being more stable when stored separately from the consumable aqueous medium is separated from the consumable aqueous medium having a pH greater than or equal to 7.

23. A dietary supplement container according to claim 9 , wherein the ingredient being more stable when stored separately from the consumable aqueous medium is separated from the consumable aqueous medium being more acidic than the unstable ingredient.

24. A dietary supplement container according to claim 9 , wherein the ingredient being more stable when stored separately from the consumable aqueous medium is separated from the consumable aqueous medium being more basic than the unstable ingredient.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded May 29, 2026
From: ROYAL BANK OF CANADA
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 075647/0267 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SERIAL NUMBER OF PATENT NUMBER 7,645,812 TO 7,465,812 PREVIOUSLY RECORDED AT REEL: 059662 FRAME: 0958. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Apr 26, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059793/0777 →
SECURITY INTEREST Recorded Apr 21, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059662/0958 →
MERGER Recorded Aug 14, 2016
From: NORTHERN INNOVATIONS HOLDING CORP.
To: OLD NORTHERN INNOVATIONS CORP.
Reel/Frame 039427/0336 →
CHANGE OF NAME Recorded Aug 14, 2016
From: 2462096 ONTARIO LIMITED
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 039672/0990 →
CHANGE OF NAME Recorded Aug 14, 2016
From: NORTHERN INNOVATIONS HOLDING CORP.
To: OLD NORTHERN INNOVATIONS CORP.
Reel/Frame 039672/0994 →
CHANGE OF NAME Recorded Aug 14, 2016
From: 2508304 ONTARIO LIMITED
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 039673/0027 →
MERGER Recorded Aug 14, 2016
From: NORTHERN INNOVATIONS AND FORMULATIONS CORP.
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 039672/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2016
From: OLD NORTHERN INNOVATIONS CORP.
To: 2462096 ONTARIO LIMITED
Reel/Frame 039427/0313 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2016
From: OLD NORTHERN INNOVATIONS CORP.
To: 2508304 ONTARIO LIMITED
Reel/Frame 039427/0326 →
MERGER Recorded Mar 23, 2010
From: NEW CELL FORMULATIONS, LTD.
To: NORTHERN INNOVATIONS AND FORMULATIONS CORP
Reel/Frame 024126/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2006
From: GARDINER, PAUL T.; HEUER, MARVIN A.; CHAUDHURI, SHAN; RAMSBOTTOM, JAMES D.
To: NEW CELL FORMULATIONS LTD.
Reel/Frame 018001/0226 →